Debenzergoline
Pharmaceutical compound
Debenzergoline, or propyldebenzergoline, is a dopamine receptor agonist and partial ergoline. It is an analogue of ergoline in which the A ring of the ergoline ring system has been removed. The drug strongly inhibits prolactin secretion and produces antiparkinsonian effects in rodents. Debenzergoline was first described in the scientific literature by 1980.
Sources and credits
This article is adapted from the Wikipedia article “Debenzergoline”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Images, from Wikimedia Commons:
- Debenzergoline structure.svg by AlyInWikiWonderland, Public domain
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.
